BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26008223)

  • 21. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation.
    Todorov LD; Mihaylova-Todorova S; Westfall TD; Sneddon P; Kennedy C; Bjur RA; Westfall DP
    Nature; 1997 May; 387(6628):76-9. PubMed ID: 9139824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of ectonucleotidases in the rodent brain revisited.
    Langer D; Hammer K; Koszalka P; Schrader J; Robson S; Zimmermann H
    Cell Tissue Res; 2008 Nov; 334(2):199-217. PubMed ID: 18843508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular purine metabolism in blood vessels (Part II): Activity of ecto-enzymes in blood vessels of patients with abdominal aortic aneurysm.
    Lecka J; Bloch-Boguslawska E; Molski S; Komoszynski M
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):650-7. PubMed ID: 20460346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors.
    Timóteo MA; Carneiro I; Silva I; Noronha-Matos JB; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
    Biochem Pharmacol; 2014 Jan; 87(2):371-9. PubMed ID: 24269631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of ecto-purines in inflammation leading to demyelination - new means for therapies against multiple sclerosis].
    Cieślak M; Komoszyński M
    Neurol Neurochir Pol; 2011; 45(5):489-99. PubMed ID: 22127945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectonucleotidases in Inflammation, Immunity, and Cancer.
    Haas CB; Lovászi M; Braganhol E; Pacher P; Haskó G
    J Immunol; 2021 May; 206(9):1983-1990. PubMed ID: 33879578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens.
    Holck MI; Marks BH
    J Pharmacol Exp Ther; 1978 Apr; 205(1):104-17. PubMed ID: 204767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecto-nucleotidase inhibitors: recent developments in drug discovery.
    Baqi Y
    Mini Rev Med Chem; 2015; 15(1):21-33. PubMed ID: 25694081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine monophosphate as a mediator of ATP effects at P1 purinoceptors.
    Ross FM; Brodie MJ; Stone TW
    Br J Pharmacol; 1998 Jun; 124(4):818-24. PubMed ID: 9690876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vas deferens neuro-effector junction: from kymographic tracings to structural biology principles.
    Navarrete LC; Barrera NP; Huidobro-Toro JP
    Auton Neurosci; 2014 Oct; 185():8-28. PubMed ID: 24956963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purinergic Signaling in the Cardiovascular System.
    Burnstock G
    Circ Res; 2017 Jan; 120(1):207-228. PubMed ID: 28057794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of ectonucleotidases: relevance for the treatment of cardiovascular disorders.
    Mathieu P
    Eur J Pharmacol; 2012 Dec; 696(1-3):1-4. PubMed ID: 23000390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic conversion of ATP to adenosine contributes to ATP-induced inhibition of glutamate release in rat medullary dorsal horn neurons.
    Choi IS; Cho JH; Lee MG; Jang IS
    Neuropharmacology; 2015 Jun; 93():94-102. PubMed ID: 25656480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purinergic signaling in scarring.
    Ferrari D; Gambari R; Idzko M; Müller T; Albanesi C; Pastore S; La Manna G; Robson SC; Cronstein B
    FASEB J; 2016 Jan; 30(1):3-12. PubMed ID: 26333425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the release of the sympathetic neurotransmitter ATP and soluble nucleotidases from the guinea pig vas deferens.
    Mihaylova-Todorova S; Todorov LD; Westfall DP
    J Pharmacol Exp Ther; 2001 Jan; 296(1):64-70. PubMed ID: 11123363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Purinergic signals].
    Lazarowski ER; Schwarzbaum PJ
    Medicina (B Aires); 2009; 69(2):267-76. PubMed ID: 19435702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of alkaline phosphatase: an emerging new drug target.
    al-Rashida M; Iqbal J
    Mini Rev Med Chem; 2015; 15(1):41-51. PubMed ID: 25694083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications.
    Grković I; Drakulić D; Martinović J; Mitrović N
    Curr Neuropharmacol; 2019; 17(1):84-98. PubMed ID: 28521702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings.
    Magalhães-Cardoso MT; Pereira MF; Oliveira L; Ribeiro JA; Cunha RA; Correia-de-Sá P
    J Physiol; 2003 Jun; 549(Pt 2):399-408. PubMed ID: 12679375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Existence of P2-purinoceptors on human and porcine granulosa cells.
    Kamada S; Blackmore PF; Oehninger S; Gordon K; Hodgen GD
    J Clin Endocrinol Metab; 1994 Mar; 78(3):650-6. PubMed ID: 8126137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.